Sionna Therapeutics to Present Data at the 2026 North American Cystic Fibrosis Conference Oct 8, 2026 04:30PM
Sionna cuts 46% of staff, pivots to new CF drug combination Sep 14, 2026 04:01PM
Sionna Therapeutics Announces Plans to Advance SION-451 + SION-2222 Dual Combination into Phase 2a Proof-of-Concept Trial Sep 14, 2026 04:01PM